Earnings Feed
Start Free
Home/Filings/4/0001127602-25-013046
4//SEC Filing

Davis Robert M 4

Accession 0001127602-25-013046

CIK 0000310158other
View on SEC.govCompany Profile

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 6:07 PM ET

Size

8.5 KB

Accession

0001127602-25-013046

Insider Transaction Report

Form 4
Period: 2025-04-29
Merck & Co., Inc.MRK
Davis Robert M
DirectorChairman, CEO & President
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-04-29+181,623→ 181,623 total
    Exercise: $84.71From: 2026-04-29Exp: 2035-04-28→ Common Stock (181,623 underlying)
  • Award

    Restricted Stock Unit

    2025-04-29+39,901→ 39,901 total
    From: 2026-04-29Exp: 2028-04-29→ Common Stock (39,901 underlying)
Holdings

  • Common Stock

    443,601.757
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F2]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
  • [F3]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.

Documents

1 file

Issuer

Merck & Co., Inc.

CIK 0000310158

→
Entity typeother

Related Parties

1
  • filerCIK 0001363076

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 6:07 PM ET
Size
8.5 KB
View on SEC.gov